Vagus nerve stimulation therapy in depression and epilepsy: therapeutic parameter settings
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Vagus nerve stimulation (VNS) therapy is an effective adjunctive treatment for chronic or recurrent treatment-resistant depression in adults, and for pharmacoresistant epilepsy in adults and adolescents. VNS therapy is administered through an implanted pulse generator that delivers programmed electrical pulses through an implanted lead to the left vagus nerve. Programmable pulse parameters include output current, frequency, pulse width, and ON/OFF times. Within a range of typical values, individual patients respond best to different combinations of parameter settings. The physician must identify the optimum settings for each patient while balancing the goals of maximizing efficacy, minimizing side effects, and preserving battery life. Output current is gradually increased from 0.25 mA to the maximum tolerable level (maximum, 3.5 mA); typical therapeutic settings range from 1.0 to 1.5 mA. Greater output current is associated with increased side effects, including voice alteration, cough, a feeling of throat tightening, and dyspnea. Frequency is typically programmed at 20 Hz in depression and 30 Hz in epilepsy. Pulse width is typically 250 or 500 micros. The recommended initial ON time is 30 s, followed by 5 min OFF; OFF time > ON time is recommended. As with pharmacotherapy, VNS therapy must be adjusted in a gradual, systematic fashion to individualize therapy for each patient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vagus-nerve stimulation for the treatment of epilepsy
Ben-Menachem, E. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00220-x · Cited by 560
Prospective Long‐Term Study of Vagus Nerve Stimulation for the Treatment of Refractory Seizures
DeGiorgio, C. M., Schachter, S. C., Handforth, A., Salinsky, M., Thompson, J., Uthman, B., Reed, R., Collin, S., Tecoma, E., Morris, G. L., et al. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00325.x · Cited by 479 · cited 5×
“We also analyzed a controlled multicenter study (E05) of acute and long-term VNS therapy in 194 patients with intractable epilepsy (2, 10, 14) (Table 1).”
BackgroundMethodInfluentialSelf-citationVagus nerve stimulation, side effects, and long-term safety
Ben-Menachem, E. (2001) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-200109000-00005 · Cited by 400
Effects of Vagal Stimulation on Experimentally Induced Seizures in Rats
Woodbury, D. M., & Woodbury, J. W. (1990) · Epilepsia · doi:10.1111/j.1528-1157.1990.tb05852.x · Cited by 369 · cited 2×
“This change was based on data from animal studies by Woodbury and Woodbury suggesting that 20 Hz was sufficient for stimulation (24).”
MethodConsiderations for Safety with Chronically Implanted Nerve Electrodes
Agnew, W. F., & McCreery, D. B. (1990) · Epilepsia · doi:10.1111/j.1528-1157.1990.tb05845.x · Cited by 184
Cited by
Tracey, K. J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2566 · Cited by 1,154
“Vagus nerve stimulators are currently in clinical use and have been safely implanted in tens of thousands of patients as a treatment for seizure disorders that are refractory to medicatio”
BackgroundYap, J. Y. Y., Keatch, C., Lambert, E., Woods, W., Stoddart, P. R., & Kameneva, T. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00284 · Cited by 432
Effects of vagus nerve stimulation on rat hippocampal progenitor proliferation
Revesz, D., Tjernstrom, M., Ben-Menachem, E., & Thorlin, T. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.08.012 · Cited by 126
Sackeim, H. A., Dibué, M., Bunker, M. T., & Rush, A. J. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s286977 · Cited by 15
Metadata
- Authors
- Labiner, D. M., & Ahern, G. L.
- Venue
- Acta Neurologica Scandinavica
- Publisher
- Hindawi Limited
- Published
- 2007-01
- Volume
- 115
- Issue
- 1
- Pages
- 23-33
- ISSN
- 0001-6314 (ISSN-L)
- 1600-0404
- OpenAlex
- W2025606262
- Cited by
- 92
- References
- 5
- FWCI
- 4.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vagus nerve stimulation therapy in depression and epilepsy: therapeutic parameter settings. https://app.cochat.ai/papers/10.1111/j.1600-0404.2006.00732.x
- The paper
- Labiner, D. M., & Ahern, G. L. (2007). Vagus nerve stimulation therapy in depression and epilepsy: therapeutic parameter settings. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.2006.00732.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.